Moreover, a high level of UBE2C expression was associated with tumorigenesis, poor cell differentiation and lymph node invasion in OSCC patients and with poor DSS in TSCC patients having poor cell differentiation, advanced pathological stages and lymph node metastasis and receiving radiation therapy. This evidence concerns the gene UBE2C and metastatic malignant neoplasm in the lymph nodes.